Human neutrophil lipocalin (HNL) as a biomarker of acute infections

References

• Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057–98.
   PubMed Web of Science ®Google Scholar
• Nathan C, Cars O. Antibiotic resistance–problems, progress, and prospects. N Engl J Med. 2014;371:1761–3.
   PubMed Web of Science ®Google Scholar
• Jasovsky D, Littmann J, Zorzet A, Cars O. Antimicrobial resistance-a threat to the world’s sustainable development. Ups J Med Sci. 2016;121:159–64.
   PubMed Web of Science ®Google Scholar
• Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkens PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract. 2003;53:358–64.
   PubMed Web of Science ®Google Scholar
• Hopstaken RM, Stobberingh EE, Knottnerus JA, Muris JW, Nelemans P, Rinkens PE, et al. Clinical items not helpful in differentiating viral from bacterial lower respiratory tract infections in general practice. J Clin Epidemiol. 2005;58:175–83.
   PubMed Web of Science ®Google Scholar
• Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta. 2000;1482:298–307.
   PubMed Web of Science ®Google Scholar
• Xu SY, Carlson M, Engstrom A, Garcia R, Peterson CG, Venge P. Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest. 1994;54:365–76.
   PubMed Web of Science ®Google Scholar
• Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425–32.
   PubMed Web of Science ®Google Scholar
• Cai L, Borowiec J, Xu S, Han W, Venge P. Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances. Clin Chim Acta. 2009;403:121–5.
   PubMed Web of Science ®Google Scholar
• Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–8.
   PubMed Web of Science ®Google Scholar
• Abella V, Scotece M, Conde J, Gomez R, Lois A, Pino J, et al. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers. 2015;20:565–71.
   PubMed Web of Science ®Google Scholar
• Cai L, Rubin J, Han W, Venge P, Xu S. The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol. 2010;5:2229–35.
   PubMed Web of Science ®Google Scholar
• Martensson J, Xu S, Bell M, Martling CR, Venge P. Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. Clin Chim Acta. 2012;413:1661–7.
   PubMed Web of Science ®Google Scholar
• Friedl A, Stoesz SP, Buckley P, Gould MN. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J. 1999;31:433–41.
   PubMedGoogle Scholar
• Xu SY, Pauksens K, Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest. 1995;55:125–31.
   PubMed Web of Science ®Google Scholar
• Pauksens K, Fjaertoft G, Douhan-Hakansson L, Venge P. Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia. Scand J Infect Dis. 2008;40:326–37.
   PubMed Web of Science ®Google Scholar
• Yu Z, Jing H, Hongtao P, Furong J, Yuting J, Xu S, et al. Distinction between bacterial and viral infections by serum measurement of human neutrophil lipocalin (HNL) and the impact of antibody selection. J Immunol Methods. 2016;432:82–6.
   PubMed Web of Science ®Google Scholar
• Bjorkqvist M, Kallman J, Fjaertoft G, Xu S, Venge P, Schollin J. Human neutrophil lipocalin: normal levels and use as a marker for invasive infection in the newborn. Acta Paediatr. 2004;93:534–9.
   PubMed Web of Science ®Google Scholar
• Fjaertoft G, Foucard T, Xu S, Venge P. Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics. Acta Paediatr. 2005;94:661–6.
   PubMed Web of Science ®Google Scholar
• Torsteinsdottir I, Hakansson L, Hallgren R, Gudbjornsson B, Arvidson NG, Venge P. Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis. Rheumatology (Oxford). 1999;38:1249–54.
   PubMed Web of Science ®Google Scholar
• Eichler I, Nilsson M, Rath R, Enander I, Venge P, Koller DY. Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis. Eur Respir J. 1999;14:1145–9.
   PubMed Web of Science ®Google Scholar
• Ekberg-Jansson A, Andersson B, Bake B, Boijsen M, Enanden I, Rosengren A, et al. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med. 2001;95:363–73.
   PubMed Web of Science ®Google Scholar
• Lannergard A, Hersio K, Larsson A, Pauksens K, Venge P, Stahle E, et al. Evaluation of laboratory markers for the detection of infections in open-heart surgery patients. Scand J Infect Dis. 2003;35:121–6.
   PubMed Web of Science ®Google Scholar
• Venge P, Douhan-Hakansson L, Garwicz D, Peterson C, Xu S, Pauksens K. Human neutrophil lipocalin as a superior diagnostic means to distinguish between acute bacterial and viral infections. Clin Vaccine Immunol. 2015;22:1025–32.
   PubMed Web of Science ®Google Scholar
• Venge P, Hakansson LD, Garwicz D, Peterson C, Xu S, Pauksens K. Human neutrophil lipocalin in fMLP-activated whole blood as a diagnostic means to distinguish between acute bacterial and viral infections. J Immunol Methods. 2015;424:85–90.
   PubMed Web of Science ®Google Scholar
• Venge P, Eriksson AK, Douhan-Hakansson L, Pauksens K. Human neutrophil lipocalin in activated whole blood is a specific and rapid diagnostic biomarker of bacterial infections in the respiratory tract. Clin Vaccine Immunol. 2017;24:e00064–17.
   PubMed Web of Science ®Google Scholar